CARDINAL HEALTH INC
CAHdata completeness 88%19 fiscal years on fileData notes: no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'realEstateImpairment'
The estimate methods put fair value between $36.13 and $423.01 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|
| Revenue | $181.3B1 | $205B2 | $226.8B3 | $222.6B3 | $254.2B3 |
| Net income | −$938M4 | $330M5 | $852M6 | $1.56B6 | $1.71B6 |
| Operating cash flow | $3.18B7 | $2.84B8 | $3.76B9 | $2.4B9 | $5.17B9 |
| Capital expenditure | $387M10 | $481M11 | $511M12 | $547M12 | $649M12 |
| Free cash flow (derived) | $2.79B7 | $2.36B8 | $3.25B9 | $1.85B9 | $4.53B9 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $4.72B13 | $4.08B14 | $5.13B15 | $3.87B16 | $4.86B16 |
| Diluted shares | 279.0M | 262.0M | 247.0M | 242.0M | 237.0M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$121.65 of net worth that earned you $72.32 and generated $190.93 of cash last year.
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Share count is down 15% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
The 3 estimate methods that apply put fair value between $36.13 and $423.01 a share. They rest on different assumptions, so where they diverge is the story.
assumptions (10)
- riskFreeRate5.0%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears10
- fcfGrowth11.2%
- fcfBase$3.25B
assumptions (10)
- riskFreeRate5.0%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears5
- fcfGrowth11.2%
- fcfBase$3.25B
assumptions (8)
- riskFreeRate5.0%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$852M
- growthAssumed0.0%
Different models answer different questions — which to trust when →
| Bear | 0.0% | $208.11 |
| Base | 11.2% | $321.96 |
| Bull | 16.2% | $388.79 |
Bear/base/bull growth = 0% / filed history / history + 5pp. Type a price to see the return each case implies.
Default growth 11.2%= this company’s own filed history (median-to-median FCF CAGR, clamped 0–20%). Your adjustments are recorded anonymously. They become the “what do owners actually believe” dataset.
- 10-K · period ending 2022-06-30 · accession 0000721371-24-000056 (Revenues)
- 10-K · period ending 2023-06-30 · accession 0000721371-25-000079 (Revenues)
- 10-K · period ending 2024-06-30 · accession 0000721371-26-000038 (Revenues)
- 10-K · period ending 2022-06-30 · accession 0000721371-24-000056 (NetIncomeLoss)
- 10-K · period ending 2023-06-30 · accession 0000721371-25-000079 (NetIncomeLoss)
- 10-K · period ending 2024-06-30 · accession 0000721371-26-000038 (NetIncomeLoss)
- 10-K · period ending 2022-06-30 · accession 0000721371-24-000056 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-06-30 · accession 0000721371-25-000079 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-06-30 · accession 0000721371-26-000038 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-06-30 · accession 0000721371-24-000056 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-06-30 · accession 0000721371-25-000079 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-06-30 · accession 0000721371-26-000038 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-06-30 · accession 0000721371-23-000060 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-06-30 · accession 0000721371-24-000056 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-06-30 · accession 0000721371-25-000079 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2025-06-30 · accession 0000721371-26-000038 (CashAndCashEquivalentsAtCarryingValue)